ARCHIVES

Blinatumomab Shows Response In Adults with Refractory ALL

This article is from The Cancer Letter archive.

Vol. 35 No. 5 | May 25, 2012

Download PDF Visit The Full Archive

Related Articles

DeVita Will Ask NTP To Return Some NCI Funs To help Cover Shortfall In Center Core Budget

January 18, 1980

Fisher Unable To Answer Key Questions, Blames NCI, A Second Hearing On NSABP

June 24, 1994

FDA Committee Approves NDA for Mitxantrone

March 21, 1986

NIH Signs Agreement For Use Of Five Stem Cell Lines.

September 7, 2001

NIH Programs: Varmus Appoints 20 To Council of Public Representatives

April 30, 1999

Cancer Trials Take 800 Days To Start On Average; NCI Vows Improvement.

April 11, 2008